From Cost Advantage to Value Advantage: The Next Frontier for Generic Manufacturers
Companies are now better positioned to redesign how they compete and create long‑term value.
Opinion
Beauty at Walmart gets makeover
Shoppers can currently find Beauty 2.0 in some 150 Walmart stores, with 300 more conversions expected by the end of 2026.
Expect B-T-S shoppers to favor stores
The takeaway for retailers isn’t to shout louder about price. It’s to prove, aisle by aisle, that being in-store still delivers what shoppers need, when they need it.
NACDS makes a welcome change
David Pinto examines some of the possible changes the NACDS Annual will have in 2027.
Community pharmacy’s next chapter: Turning industry challenges into opportunity
By Mike Wysong, chief executive officer of CARE Pharmacies
Sociability is inherent to shopping
With stores woven into the fabric of neighborhoods where people live and work, traditional merchants are ideally situated to build connections.
$4.50-a-gallon gas has disparate effects
When it comes to gas prices, club membership looks like a bargain.
Why the musical chairs in C-Suites?
David Pinto examines the recent departure of Musab Balbale from CVS.
Filling the care gap for women
By Rich Kaminski is the research director at WSL Strategic Retail
Pharmacy is being disrupted: How retail pharmacies should respond and rethink strategic planning
By Todd Huseby is a partner at Kearney, a global management consulting firm. Michael Carr and Tonny Huang are principals at Kearney
Two titans are speeding change
Both retail titans are moving with alacrity to reinvent their core business, even as they invest billions of dollars in other relevant fields — most notably artificial intelligence.
Retailers face a new economic reality
What makes this moment particularly challenging is that consumers are not simply “trading down” in the traditional sense. They are redefining value altogether.
An invaluable event can be tweaked
David Pinto does a postmortem of the NACDS Annual and looks for areas to improve the event.
Employers wary of GLP-1 costs
Other new research, from Acosta Group, reveals that GLP-1s are reshaping consumer behavior including lifestyle, health and wellness, and personal care choices.
An Rx for affordable health care
The entire system would benefit from directing consumers to the lowest-cost point of care.